Jane Rhyu, Sylvia Lambrechts, Maria A Han, Matthew J Freeby
Curr Opin Endocrinol Diabetes Obes. 2022;29(1):29-33
In this review article, the authors describe HbA1c testing as a marker of glycemic control and the standard for diabetes risk assessment. They highlight that many diabetes patients have uncontrolled diabetes, increasing the risk of microvascular complications. They explain that a lack of HbA1c monitoring presents a significant barrier and that improving ease of testing could improve glycemic control.
Point-of-care testing (POCT) for HbA1c provides results immediately and is available and used frequently in endocrine clinics. However, the authors describe how testing is not standard in primary care, where 90% of type 2 diabetes patients are treated. Barriers include access and costs of POCT machines and standardisation of testing in the primary care setting. The authors cite that POCT in primary care may lead to HbA1c reduction, is potentially cost-effective and may also strengthen the patient-physician relationship.
The authors conclude that POCT in primary care, if widely available and integrated into workflow, has the potential to positively impact diabetes care by allowing earlier therapeutic intervention.
The full publication can be accessed here.
© 2022 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. COL-12692 08/2022
&copie; 2022 Abbott. Tous les droits sont réservés. Toutes les marques commerciales référencées sont des marques commerciales du groupe de sociétés Abbott ou de leurs propriétaires respectifs.